Kiniksa Pharmaceuticals International will announce its first quarter 2026 financial results on April 28, 2026, at 8:30 a.m. Eastern Time. The company will host a conference call and live webcast accessible through its website, offering investors and media a chance to hear about recent portfolio developments and financial performance. A replay of the event will be available about 48 hours later. Kiniksa focuses on developing therapies for cardiovascular and other debilitating diseases, aiming to address unmet medical needs.
The global reactive hot melt adhesives market is projected to grow from $2.02 billion in 2025 to $4.29 billion by 2035, at a CAGR of 7.72%. Growth is driven by regulations limiting solvent-based adhesives, increased use of polyurethane adhesives in a...
Red Light Holland, after acquiring Filament Health, has expanded its capabilities in pharmaceutical-grade psilocybin development. Filament completed a shipment of its botanical psilocybin drug candidate, PEX010, to the European Union to support multi...
Wendy's is running a $1 promotion on small Classic Chocolate or Vanilla Frosty from July 20 to August 23, with early access for Wendy's Rewards members on July 19 in celebration of National Ice Cream Day. The offer is redeemable via the Wendy's app a...
Dyadic International has expanded its bio-industrial pipeline with a new proprietary enzyme program focused on advanced cellulose processing, building on the success of its EN3ZYME™ product. This initiative leverages Dyadic's Dapibus™ platform to str...
Forum Markets has acquired a commercial aircraft engine for about $12 million, increasing its aviation portfolio to four engines leased to major U.S. airlines. The engine, a widely used CFM56-7B model, is already generating revenue under a long-term ...
